Complement and microglia mediate early synapse loss in Alzheimer mouse models
Open accessThe DOI matches its Crossref record; 32 of the 33 references it cites were found in a registry or an index; 21 of the 28 sources its claims cite were checked for support.
Abstract
Too much cleaning up: The complement system and microglia seek out and destroy unwanted cellular debris for the peripheral immune system as well as excess synapses in the developing brain. Hong et al. now show how the system may go haywire in adults early in the progression toward Alzheimer's disease (AD). Aberrant synapse loss is an early feature of Alzheimer's and correlates with cognitive decline. In mice susceptible to AD, complement was associated with synapses, and microglial function was required for synapse loss. The authors speculate that aberrant activation of this “trash disposal” system underlies AD pathology. Science , this issue p. 712
Overview
CoChat Summary
TL;DR
In Alzheimer mouse models, classical complement proteins C1q and C3 increase and localize to synapses before plaques, and blocking C1q, C3, or microglial CR3 reduces early synapse loss. Soluble Aβ oligomers drive microglial engulfment of synaptic material through a CR3-dependent pathway, suggesting reactivation of developmental synaptic pruning in early AD.
Key findings
- J20 hAPP mice showed significant hippocampal synapse loss at 3–4 months, before plaque deposition; loss occurred in CA1, CA3, and dentate gyrus at 3 months but not in striatum, and was not seen at 1 month.
- C1q was elevated in J20 brains as early as 1 month, region-specifically in hippocampus and frontal cortex, and colocalized with PSD95-positive puncta; Compound E reduced soluble Aβ and C1q deposition, while oligomeric Aβ—but not monomeric Aβ or vehicle—induced C1q deposition and synaptic colocalization.
- Oligomeric Aβ induced synapse loss within 72 h in WT mice but not in C1qa knockout mice; anti-C1q antibody ANX-M1 prevented oAβ-induced synapse loss and LTP impairment, and APP/PS1xC3 KO mice did not show the synapse loss seen in 4-month APP/PS1 hippocampus.
- Microglial CD68 increased in J20 hippocampus and after oAβ; oAβ increased internalized Homer-GFP in microglia, failed to do so in CR3 KO mice, and induced hippocampal synapse loss in WT but not CR3 KO mice.
Methods
- Mouse models included J20 hAPP, APP/PS1, C1qa KO, C3 KO, CR3 KO, and Homer-GFP mice, with WT littermates and ages including 1 month, 3–4 months, and P21.
- Synapse quantification used super-resolution structured illumination microscopy, confocal imaging, and electron microscopy with colocalized pre- and postsynaptic puncta markers including synaptophysin/PSD95, synaptotagmin/homer, and synapsin/PSD95; C1q and C3 colocalization with PSD95 was also measured.
- Interventions included Compound E, intracerebroventricular or tail vein injections of soluble Aβ oligomers, monomers, or vehicle, anti-C1q antibody ANX-M1 or IgG control, acute hippocampal slice LTP recordings, and an in vivo synaptic engulfment assay.
Limitations
- The paper states that specific synaptic C1q receptors are not yet known and that oAβ and C1q may act indirectly through cytokines such as TGFβ, microglial or astrocytic activation, or other pathways including MHCI/PirB.
- The paper states that the complement pathway may not be involved in all pathological routes to AD, including plaque-associated synapse loss, and that future studies are needed to examine plaque-associated synapse loss and other synaptopathies such as tauopathies and Huntington’s disease.
- Evident from the text: the findings are from mouse models and acute hippocampal slices, not human AD tissue or clinical trials, and the study focuses on early pre-plaque mechanisms rather than established plaque-associated neuropathology.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
16 Valid · 0 Not valid · 2 Not checked · 48 Own results and interpretations
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“C1q binds synapses in vulnerable regions undergoing synapse loss (our data here; (5, 27)).”
§ Complement and Microglia Mediate Early Synapse Loss in Alzheimer Mouse Models > Abstract
What the sources say
- Supportedcites [5] Stevens B The classical complement cascade mediates CNS synapse elimination. Cell 2007 131 1164 1178 18083105 source
The Results report C1q localized to synapses in the developing dLGN during synaptic pruning and relocalized to adult retinal synapses in early glaucoma, before significant synapse loss. The Discussion likewise places synaptic C1q relocalization before or concurrent with synapse loss in the glaucoma model. (LLM, conf=0.89)
- Not checked — no full text of the sourcecites [27] Stephan AH Barres BA Stevens B The complement system: an unexpected role in synaptic pruning during development and disease. Annu. Rev. Neurosci 2012 35 369 389 22715882 source
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“suggesting that the engulfed synapses are internalized into lysosomal compartments in a manner similar to developmental synaptic pruning (6).”
§ Complement and Microglia Mediate Early Synapse Loss in Alzheimer Mouse Models > Abstract
What the sources say
- Supportedcites [6] Schafer DP Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner. Neuron 2012 74 691 705 22632727 PMC3528177 source
The Results section, “Microglia engulf RGC inputs during a period of active synaptic pruning” (page unavailable), reports that most engulfed RGC inputs colocalized with microglial lysosomal compartments. The Results section, “Microglia engulf presynaptic elements specific to RGCs” (page unavailable), also identifies an RGC presynaptic marker within microglial lysosomes, supporting the proposed similarity to developmental synaptic pruning. (LLM, conf=0.94)
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Quantification of colocalized pre- and postsynaptic puncta (synaptophysin and PSD95 (Fig. 1A); synaptotagmin and homer (figs. S1A-D)) revealed a significant loss of synapses in J20 hippocampus at 3-4 months old (mo), an age that precedes plaque deposition (11, 12).”
§ Complement and Microglia Mediate Early Synapse Loss in Alzheimer Mouse Models > Abstract
What the sources say
- Supportedcites [11] Mucke L High-Level Neuronal Expression of Abeta 1-42 in Wild-Type Human Amyloid Protein Precursor Transgenic Mice: Synaptotoxicity without Plaque Formation. Journal of Neuroscience 2000 20 4050 10818140 PMC6772621 source
The citation is attached to the statement that 3–4 months precedes plaque deposition, not to the citing authors’ synapse measurements. In “Effects of hAPP mutations on formation of amyloid plaques” (Fig. 4; page not provided), the paper assesses mice at 2–4 months and reports amyloid deposition in APP Sw,Ind mice at 5–7 months; the paper identifies J20 as an APP Sw,Ind line. (LLM, conf=0.91)
- Supportedcites [12] Hong S Dynamic Analysis of Amyloid -Protein in Behaving Mice Reveals Opposing Changes in ISF versus Parenchymal A during Age-Related Plaque Formation. Journal of Neuroscience 2011 31 15861 15869 22049429 PMC3227224 source
The citation follows the statement that 3–4 months precedes plaque deposition, rather than the citing authors’ own synapse measurements. The Results section (page unavailable) identifies approximately 3-month-old J20 mice as pre-plaque and describes 3–7-month-old mice as plaque-free. (LLM, conf=0.91)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Genome-wide association studies (GWAS) implicate microglia and complement-related pathways in AD (1).”
§ Complement and Microglia Mediate Early Synapse Loss in Alzheimer Mouse Models > Abstract
What the sources say
- Supportedcites [1] Hong S Dissing-Olesen L Stevens B New insights on the role of microglia in synaptic pruning in health and disease. Curr Opin Neurobiol 2016 doi:10.1016/j.conb.2015.12.004 PMC5479435 26745839 source
The Introduction says GWAS and integrated network studies identify immune-related AD risk pathways implicating microglia. The section on microglia–synapse dysfunction identifies GWAS variants CLU and CR1, both related to complement. Page numbers are not provided in our copy. (LLM, conf=0.93)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“C1q was also similarly increased in hippocampus of another model of AD, the APP/PS1 mice (15) (Fig. S2C).”
§ Complement and Microglia Mediate Early Synapse Loss in Alzheimer Mouse Models > Abstract
What the sources say
- Supportedcites [15] Jankowsky JL Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase. Hum. Mol. Genet 2004 13 159 170 14645205 source
The citation identifies the APP/PS1 mouse model, while the citing document points to its own Fig. S2C for the C1q increase. Figure 2 (p. 4) describes APPswe/PS1 double-transgenic mice and shows hippocampal amyloid pathology in that model. (LLM, conf=0.88)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
48 more claims · 5 with their cited sources checked
Create a free account to see all 66 claims and every source verdict.
- It may state two separate claims as one. 11
- Probably not a substantial claim. 2
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“increasing evidence demonstrate that immune signaling may not just be a consequence of protein aggregation in the brain, but that it actually causes the buildup of aggregates at the earliest stages of the disease process.15–17”
From Role of neuroinflammation in neurodegeneration development (2023) · cites this paper as [15]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In neurodegeneration, the complement pathway is activated, and inhibiting the complement proteins C1q or C3 results in less neuroinflammation, Aβ plaques and synapse loss29,30.”
From Exercise plasma boosts memory and dampens brain inflammation via clusterin (2021) · cites this paper as [30]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Before the onset of Aβ deposition, microglia engulf synapses opsonized with the complement factors C1q and C3 upon CR3-mediated recognition of C3 (121).”
From Microglia in Alzheimer's disease (2017) · cites this paper as [121]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Lack of C1q, C3, or CR3 curbed microglia activation and synaptic loss during amyloid plaque deposition.”
From Microglia Function in the Central Nervous System During Health and Neurodegeneration (2017) · cites this paper as [139]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Inappropriate control of the classical complement cascade causes unresolvable inflammation and disease (Hong et al. , 2016; Hansen, Hanson and Sheng, 2018; Morgan, 2018).”
From Spatial Transcriptomics and In Situ Sequencing to Study Alzheimer’s Disease (2020) · cites this paper as Hong et al., 2016
Experimental — accuracy not yet measured
70 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Self-check results appear here once an independent check has confirmed them.
Cited works that were retracted
Works this paper cites that were later retracted, from the retraction notices publishers deposit. Major when the notice came out before this paper was published.
A note, not an issue: for example, a cited work that was retracted only after this paper was published, which its authors could not have known.
In the paper
“It is also plausible that oAβ and C1q may work indirectly to mediate synapse loss through cytokines such as TGFβ (7), through microglial or astrocytic activation, or through other mechanisms including MHCI/PirB, another immune pathway critical for synapse elimination in development and AD (28-30).”
Cited work 10.1038/nn.3560 · retracted 2022-01-13 · notice 10.1038/s41593-021-00877-7 · this paper published 2016-05-06
Citations
Cites
1 retracted
Bialas, A. R., & Stevens, B. (2013) · Nature Neuroscience · doi:10.1038/nn.3560 · Cited by 519 · cited 2×
“It is also plausible that oAβ and C1q may work indirectly to mediate synapse loss through cytokines such as TGFβ (7), through microglial or astrocytic activation, or through other mechanisms including MHCI/PirB, another immune pathway critical for synapse elimination in development and AD (28-30).”
Self-citationRetractedAmyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Alzheimer's Disease Is a Synaptic Failure
Selkoe, D. J. (2002) · Science · doi:10.1126/science.1074069 · Cited by 4,420 · cited 1×
“Synaptic deficits occur in early AD and mild cognitively impaired patients before onset of plaques and are some of the first signs of the neuronal degenerative process (4, 23-25).”
Self-citationTerry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397 · cited 1×
“The degree of region-specific synapse loss is a stronger correlate of cognitive decline in AD than counts of plaques, tangles and neuronal loss (8, 9).”
Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner
Schafer, D. P., Lehrman, E. K., Kautzman, A. G., Koyama, R., Mardinly, A. R., Yamasaki, R., Ransohoff, R. M., Greenberg, M. E., Barres, B. A., & Stevens, B. (2012) · Neuron · doi:10.1016/j.neuron.2012.03.026 · Cited by 4,089
Self-citationThe Classical Complement Cascade Mediates CNS Synapse Elimination
Stevens, B., Allen, N. J., Vazquez, L. E., Howell, G. R., Christopherson, K. S., Nouri, N., Micheva, K. D., Mehalow, A. K., Huberman, A. D., Stafford, B., et al. (2007) · Cell · doi:10.1016/j.cell.2007.10.036 · Cited by 3,313 · cited 4×
“Although specific receptors for C1q at synapses are not yet known, C1q binds synapses in vulnerable regions undergoing synapse loss (our data here; (5, 27)).”
InfluentialSelf-citationIdentification of a unique TGF-β–dependent molecular and functional signature in microglia
Butovsky, O., Jedrychowski, M. P., Moore, C. S., Cialic, R., Lanser, A. J., Gabriely, G., Koeglsperger, T., Dake, B., Wu, P. M., Doykan, C. E., et al. (2014) · Nature Neuroscience · doi:10.1038/nn.3599 · Cited by 2,543 · cited 1×
“S11), indicating they are resident cells (22).”
Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity
DeKosky, S. T., & Scheff, S. W. (1990) · Annals of Neurology · doi:10.1002/ana.410270502 · Cited by 2,376 · cited 1×
“The degree of region-specific synapse loss is a stronger correlate of cognitive decline in AD than counts of plaques, tangles and neuronal loss (8, 9).”
Mucke, L., Masliah, E., Yu, G.-Q., Mallory, M., Rockenstein, E. M., Tatsuno, G., Hu, K., Kholodenko, D., Johnson-Wood, K., & McConlogue, L. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-11-04050.2000 · Cited by 1,856 · cited 3×
“S4), long before Aβ plaques deposit (11, 12), raising the question of whether C1q increase in these pre-plaque brains is dependent on soluble Aβ levels.”
Jankowsky, J. L., Fadale, D. J., Anderson, J., Xu, G. M., Gonzales, V., Jenkins, N. A., Copeland, N. G., Lee, M. K., Younkin, L. H., Wagner, S. L., et al. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh019 · Cited by 1,575
Cited by
Items 2,501–2,600 of 3,349
Miteva, M. T., Protto, V., Zanzi, F., Pastore, F., Simone, C., Ripoli, C., Marcocci, M. E., Piacentini, R., Grassi, C., Palamara, A. T., et al. (2026) · Cell Communication and Signaling · doi:10.1186/s12964-026-02745-y · Cited by 3
“We thus investigated the possible pruning of post-synaptic terminals upon HSV-1 infection and the role of C3 protein in this process, since it is the effector of the complement-dependent synapse opsonization [3, 14].”
Luo, M., Wang, L., Liang, Y., Xu, Q., Zhang, S., Xing, X., Niu, S., & Wang, Y. (2026) · Experimental & Molecular Medicine · doi:10.1038/s12276-026-01666-7 · Cited by 3
Chai, Y. L., Hilal, S., Cai, V. Y., Mok, V., Chong, J. R., Liao, Y., Tan, B. Y., Venketasubramanian, N., Arumugam, T. V., Chen, C. L.-H., et al. (2026) · Brain Communications · doi:10.1093/braincomms/fcag068 · Cited by 2
HDAC6 regulates BACE1 stability and NLRP3 inflammasome activation in Alzheimer's disease
Lee, J., Cho, Y., Choi, B. Y., Kim, H. K., Lee, Y., Kim, E., Han, J., Sul, J. H., Kim, J. S., Baek, S. H., et al. (2026) · Brain · doi:10.1093/brain/awag089 · Cited by 5
Microglial Neurotransmitter Receptors in Health and Disease
Bi, Q., Guo, C., Chen, N., Zhou, X., Zhou, Q., Liu, X., Shen, X. Z., & Shi, P. D. (2026) · Physiology · doi:10.1152/physiol.00030.2025 · Cited by 3
ALKBH3 m1A Demethylase Deficiency Reduces Alzheimer's Amyloid‐β Pathology
Li, Y., Yu, S. M., Lu, K., Zhang, Y., Dong, M., Peng, Y., Xue, L., Alam, W., Shui, Y., Zhou, Y., et al. (2026) · Advanced Science · doi:10.1002/advs.202522572 · Cited by 5
“We first quantified the RNA modification landscape in the hippocampus, a region central to cognitive decline [ 3, 22 ], from homozygous 6-month-old 5xFAD mice (5xFAD + / + ).”
Zurawski, J. D., Tuncer, A., Profant, M. R., Wang, J., Green, M., Park, Y., Cao, K., Paris, S., Tauhid, S., Jalkh, Y., et al. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2526147123 · Cited by 2
“Autoreactive antibodies can contribute to neuronal dysfunction through multiple, non–mutually exclusive mechanisms, including complement activation, Fc receptor–mediated microglial synaptic pruning, and direct interference with synaptic proteins (78–80).”
Gonçalves, C. B., Costa, M. R., Kanashiro, A., Pereira, D. D., Fernandes, M. S. D. S., & Souto, F. O. (2026) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2026.106645 · Cited by 3
Emerging role of cell membrane-coated nanoparticles in targeted therapy for brain disorders
Kumari, V., Shahrukh, M., Jabin, K., Ali, N., Hasan, N., Aqil, M., & Ahmad, F. J. (2026) · Biomaterials Advances · doi:10.1016/j.bioadv.2026.214822 · Cited by 4
Espinosa‐García, C., Srivastava, U., Kumar, P., Kour, D., Malepati, S., Tobin, B. R., Xiao, H., Sunna, S. N., Bowen, C. A., Cheng, L., et al. (2026) · Molecular Neurodegeneration Advances · doi:10.1186/s44477-026-00024-1 · Cited by 3
“For instance, neuroin-flammatory mediators, such as complement C3 and C1q, have been implicated in microglia-mediated synapse loss in AD [63–65].”
Yang, R., He, Y., Pan, Y., Geng, A., Huang, F., Guo, K., & Zhang, H. (2026) · Immunity & Ageing · doi:10.1186/s12979-026-00565-9 · Cited by 3
“Additionally, we examined the phagocytic marker CD68, which is highly expressed in activated microglia in AD[30, 31].”
Zhou, W.-M., Zhang, K., Ma, W.-W., Shi, Y.-Q., Dong, Y.-B., Yuan, Z.-Y., & Zhang, H. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1798053 · Cited by 3
“…of membrane homeostasis can weaken phospholipid asymmetry and induce the exposure of phosphatidylserine (PS) on the outer leaflet of the plasma membrane, a process that is particularly pronounced under conditions of elevated Ca 2+ and metabolic stress (Stevens et al., 2007; Hong et al., 2016).”
InfluentialYe, T., Lv, X., Li, Q., Liao, X., Zhan, L., Dai, C., Xiang, K., Lin, X., Sun, J., & Liu, J. (2026) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2026.106769 · Cited by 4
Microglial Plasticity in Vascular Dementia: Mechanisms and Therapeutic Reprogramming
Shukla, M., Li, J., Sun, Y., Jin, R., & Li, G. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27093719 · Cited by 3
“Evidence from multiple neurodegenerative disorders suggests that dysregulated microglia-mediated synaptic removal contributes to cognitive impairment [46,70].”
Lv, J., Yao, L., Tang, L., Li, Q., Wang, L., Yan, X., Li, M., Peng, W., Zhang, H., Guo, J., et al. (2026) · British Journal of Anaesthesia · doi:10.1016/j.bja.2026.02.024 · Cited by 3
Using iPSC models to examine neuron–glia interactions in neurodegenerative diseases
Lopez, D. M., Keavey, L., & Bowles, K. R. (2026) · Bioscience Reports · doi:10.1042/bsr20250131 · Cited by 2
Ma, J., Yang, B., Jiang, X., Wang, L., Wei, W., Cao, Y., & Li, H. (2026) · Experimental Gerontology · doi:10.1016/j.exger.2026.113177 · Cited by 4
Neuroglia in traumatic brain injury: Pathophysiology and therapeutic targeting
Suk, K. (2026) · Brain Network Disorders · doi:10.1016/j.bnd.2026.03.002 · Cited by 4
Bhattacharya, A., Fon, E. A., Dagher, A., Iturria‐Medina, Y., Stratton, J. A., Savignac, C., Stanley, J., Hodgson, L. M., Hammou, B. A., Bennett, D. A. A., et al. (2026) · GigaScience · doi:10.1093/gigascience/giag059 · Cited by 10
“Synapse loss is frequently observed as an early event of neurodegeneration in animal models [ 115–117 ].”
Bizzotto, M., You, S. F., Tamborini, M., Faggiani, E., Morini, R., Borreca, A., Zhang, R., Aladyeva, E., Nallapu, A., Ferrari, C., et al. (2026) · Neuron · doi:10.1016/j.neuron.2026.04.043 · Cited by 5
Yadav, B., Gangwar, P., Kumari, K., Yadav, A., Rao, R., Kumar, K., Verma, H., Dhiman, M., & Mantha, A. K. (2026) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2026.1835778 · Cited by 3
“It has been noted that A β triggers microglial RhoA/ROCK signaling, which exacerbates actin contractility and the abnormal removal of functional synapses (Hong et al., 2016).”
Impact of sex differences on microglial function in Alzheimer’s disease
Figueiredo, E. V., Azevedo, C. V., Penitente, A. R., Pedrosa, V. R., da Silva, V. R. C., & Longo, B. M. (2026) · Alzheimer s Research & Therapy · doi:10.1186/s13195-026-02099-0 · Cited by 3
“Complement components that support physiological synaptic pruning during neurodevelopment may become dysregulated in AD, promoting excessive complement-associated synaptic pruning and increasing neuronal vulnerability [11, 18, 20].”
Shao, M., Sun, L., Qu, W., Wang, L., Ma, N., Liu, J., Yan, T., Tian, Y., Ji, W., Xu, X., et al. (2026) · Advanced Materials · doi:10.1002/adma.74519 · Cited by 2
“This may result from direct inhibitory effects of pro-inflammatory cytokines on synaptic receptors or aberrant microglial-mediated synaptic pruning [ 39 ], providing a molecular basis for the signal degradation often observed with chronic neural implants.”
Aberrant excitatory neuronal ERBB4 promotes Alzheimer’s disease pathology
Lee, S. Y., Park, E., Lee, H.-E., Kim, S., Yeo, Y., Park, J., Choi, Y.-J., Lee, K., Yoon, K., Park, S., et al. (2026) · Nature · doi:10.1038/s41586-026-10964-z · Cited by 6
The contribution of inflammation to Alzheimer's disease in Down syndrome
Martini, A. C., Kloske, C. M., Wilcock, D. M., & Head, E. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-818845-3.00016-5 · Cited by 3
Pearson, C. A., & Iadecola, C. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2204159119 · Cited by 3
Aging, Dementia, and Alzheimer Disease
Sontheimer, H. W. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821228-8.00004-4 · Cited by 2
Chen, Q., Sun, T., Li, D., Zhao, Z., & Li, Y. (2022) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2022.111042 · Cited by 4
Sporadic Alzheimer’s disease animal model using streptozotocin and APP/PS1 mice
Kelliny, S., Deng, I. B., Zhou, X., & Bobrovskaya, L. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-89833-1.00026-4 · Cited by 4
Mela, V., Gaban, A. S., Shatz, P. M., Guillot‐Sestier, M., & Lynch, M. A. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03235-9 · Cited by 2
“In contrast, phagocytosis of synaptosomes is dependent on the complement pathway and, in models of AD, inappropriate engulfment of synapses by microglia is responsible for synapse loss [32].”
BackgroundPrenatal-induced psychopathologies: All roads lead to microglia
Lebow, M., Kuperman, Y., & Chen, A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-817558-3.00016-0 · Cited by 3
Microglia: a potential target for neurological disorder
Parajuli, B., & Koizumi, S. (2023) · Folia Pharmacologica Japonica · doi:10.1254/fpj.23005 · Cited by 2
Activation of Systemic- and Intracellular Complement by Cholesterol Crystals
Niyonzima, N., Kemper, C., Halvorsen, B. L., Mollnes, T. E., & Espevik, T. (2023) · Contemporary cardiology · doi:10.1007/978-3-031-41192-2_14 · Cited by 3
Chakravorty, A., Sheeba, V., & Manjithaya, R. R. (2024) · Methods in molecular biology · doi:10.1007/978-1-0716-3662-6_9 · Cited by 2
Kemper, C. (2024) · Trends in Immunology · doi:10.1016/j.it.2024.03.003 · Cited by 2
C1q is elevated during chronic Staphylococcus epidermidis central nervous system catheter infection
Beaver, M., Bergdolt, L., Dunaevsky, A., Kielian, T., & Skar, G. L. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1342467 · Cited by 3
“Complement activation and pathological synaptic pruning have also been described in several neurodegenerative conditions, such as Alzheimer ’ s disease, multiple sclerosis, traumatic brain injury, and stroke (18 – 20).”
BackgroundSun, B., & Jiang, H. (2024) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2024.112636 · Cited by 3
Rentsch, P., Ganesan, K., Langdon, A., Konen, L. M., & Vissel, B. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1421900 · Cited by 4
Jha, A., & Kumar, H. (2024) · Neuroglia · doi:10.3390/neuroglia5030017 · Cited by 3
“The aberrant release of lysosomal cathepsins (such as cathepsin C [62], H [63], and X [64]), results in lysosomal membrane permeabilization caused by impaired lysosomal acidification within the microglia.”
BackgroundSung, H.-H., Li, H., Huang, Y., Ai, C.-L., Hsieh, M.-Y., Jan, H., Peng, Y., Lin, H., Yeh, C.-H., Lin, S., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-51581-6 · Cited by 3
“Overall, I do not get a clear idea of how they perceive the galectins work in ways consistent with their data and existing knowledge of the field.”
Emerging Microglial Therapies and Targets in Clinical Trial
Yan, L., & Crotti, A. (2024) · Advances in neurobiology · doi:10.1007/978-3-031-55529-9_35 · Cited by 3
Church, K. A., Cardona, A. E., & Hopp, S. C. (2024) · Advances in neurobiology · doi:10.1007/978-3-031-55529-9_15 · Cited by 1
Immunoglobulin G and Complement as Major Players in the Neurodegeneration of Multiple Sclerosis
Kennedy, P. G. E., Fultz, M., Phares, J., & Yu, X. (2024) · Biomolecules · doi:10.3390/biom14101210 · Cited by 4
“When bound by this ligand, microglia become activated, initiating the inflammatory response and phagocytosis, which is a potential mechanism of early synaptic loss in AD, resulting in memory impairments in mouse models [74].”
BackgroundDiethyl butylmalonate attenuates cognitive deficits and depression in 5×FAD mice
Yuan, L., Song, G., Xu, W., Liu, S., Zhang, Y., Pan, W., Ding, X., Fu, L., Lin, Q., & Sun, F. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1480000 · Cited by 3
Wang, P., Hu, J., Chen, C., Jiang, Z., Zhang, Y., Lin, K., Liao, L., & Wang, X. (2024) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2024.111194 · Cited by 2
Madeshiya, A. K., Quintanilla, B., Whitehead, C., Tomlinson, S., & Pillai, A. (2024) · Cells · doi:10.3390/cells13231988 · Cited by 2
“Moreover, blocking C1q, C3, or the microglial complement receptor CR3 lowers the quantity of phagocytic microglia and mitigates early synapse loss in mouse models of early Alzheimer’s disease [77].”
Sharo, C., Zhang, J., Zhai, T., Bao, J., Garcia-Epelboim, A. D., Mamourian, E., Shen, L., & Huang, Z. J. (2024) · Targets · doi:10.3390/targets2040025 · Cited by 3
“Additionally, complement C3 has been suggested as an astroglia initiator of nuclear factor-κ B (NF κ B) signaling via neuronal C3aR, a G-protein-coupled receptor present in various cell types [101].”
Revisiting Functional Heterogeneity of Microglia and Astroglia
Kotova, M. M., Apukhtin, K. V., Nikitin, S. V., & Kalueff, A. V. (2024) · Journal of Evolutionary Biochemistry and Physiology · doi:10.1134/s0022093024060036 · Cited by 2
“…disease, a decrease in C3 leads to suppression of M1 microglia and pro-inflammatory cytokines, thereby attenuat(cid:2) ing neurodegeneration [111], while an increase in the level of this protein, on the contrary, enhances microglial phagocytosis and thus promotes early synapse destruction [112].”
Yang, H.-B., Lu, D.-C., Shu, M., Li, J., & Ma, Z. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114049 · Cited by 2
Xiong, L., He, R. Q., Du, R., Niu, R., Xue, L., Chen, L., Huangfu, L., Xiao, Q., Li, J., Li, Y., et al. (2025) · MedComm · doi:10.1002/mco2.70114 · Cited by 5
“These processes are known to play a critical role in AD progression, as synaptic dysfunction and structural abnormalities are hallmark features of AD pathology in humans [61– 63].”
EXOSOMES AS MEDIATORS OF NEUROINFLAMMATION IN PARKINSON'S DISEASE: A REVIEW
Sheikh, M., Saiyyad, A., & Jirvankar, P. (2025) · International Journal of Applied Pharmaceutics · doi:10.22159/ijap.2025v17i3.53756 · Cited by 2
“Hong et al. (2016) reported that the immune complement system contributes significantly to synaptic loss and correlated deficits in cognition in AD patients.”
Dujardin, P., Foroozandeh, J., Verhaegen, R., Burgelman, M., Nolf, C. D., Wonterghem, E. V., Imschoot, G. V., Peelaerts, W., Hochepied, T., Hoecke, L. V., et al. (2026) · Molecular Neurodegeneration Advances · doi:10.1186/s44477-026-00027-y · Cited by 2
“By deleting C3 in adult mice, we circumvent its potential roles during CNS development, including synaptic pruning and early immune regulation that might otherwise influence plaque initiation or aggregation events [11, 12, 25, 92].”
Hou, L., Xin, L., Liu, Y., He, B., Shi, C., & Yang, Y. (2025) · Behavioural Brain Research · doi:10.1016/j.bbr.2025.115711 · Cited by 2
Hu, Y., Pan, Z., Li, J., Tang, B., Luo, M., Li, Y., Cao, X., Zheng, K., Wang, N., & Xu, C. (2025) · Journal of Alzheimer s Disease Reports · doi:10.1177/25424823251356300 · Cited by 2
“14,18,19 In recent years, signi fi cant progress has been made in the development of anti-amyloid therapies that target A β .”
Dual Role of Microglial TREM2 in Neuronal Degeneration and Regeneration after Axotomy
Pottorf, T. S., Lane, E. L., Haley-Johnson, Z., Ukmar, D. N., Amores-Sanchez, V., Correa-Torres, P. M., & Álvarez, F. J. (2026) · Journal of Neuroscience · doi:10.1523/jneurosci.0112-26.2026 · Cited by 2
The tale of donanemab: God is in the details
Saido, T. C., & Iwata, N. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251371240 · Cited by 2
“Human brain tissues were kindly provided by Dr. David or a complement complex, C1q, 55,56 faster than the other isoforms.”
Glia inflammation and cell death pathways drive disease progression in preclinical and early AD
Woo, M. S., Therriault, J., Hosseini, S. A., Wang, Y.-T., Macedo, A. C., Rahmouni, N., Aumont, É., Servaes, S., Tissot, C., Arias, J. F., et al. (2025) · EMBO Molecular Medicine · doi:10.1038/s44321-025-00316-1 · Cited by 7
“…in the brain and CSF of people along the AD continuum, as well as identi fi cation of several activated glia states in postmortem histopathological and single-cell-sequencing studies (Gate et al, 2020; Mathys et al, 2024; Sung et al, 2023; Hong et al, 2016; Chen et al, 2023; Green et al, 2024).”
Morphological Representation of C1q in the Aging Central Nervous System
Rupprecht, C., Sarker, R. S. J., & Rammes, G. (2022) · Pharmacopsychiatry · doi:10.1055/a-1704-8260 · Cited by 3
Training Microglia to Resist Alzheimer's Disease
Vieira, M. N. N., & Beckman, D. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.3345-16.2017 · Cited by 2
“…enrichment boosts neuronal plasticity and induces adult neurogenesis, while reducing neuroinflammation and neurodegeneration (Fischer, 2016), and in animal models of AD, environmental enrichment has been shown to ameliorate cognitive phenotypes (Jankowsky et al., 2005; Blázquez et al., 2014).”
BackgroundSchizophrenia genetics comes to translation
Domenici, E. (2017) · Schizophrenia · doi:10.1038/s41537-017-0011-y · Cited by 4
Li, R., Li, Q., Chu, X., Tao, T., Li, L., He, C., & Gao, F.-Y. (2017) · Bioscience Reports · doi:10.1042/bsr20170335 · Cited by 2
Sex differences in microglia as a risk factor for Alzheimer’s disease
Delage, C. I., Rendina, D. N., Malacon, K. E., Tremblay, M., & Bilbo, S. D. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819344-0.00008-9 · Cited by 4
Biophysics is reshaping our perception of the epigenome: from DNA-level to high-throughput studies
Kanapeckaitė, A., Burokienė, N., Mažeikienė, A., Cottrell, G. S., & Widera, D. (2021) · Biophysical Reports · doi:10.1016/j.bpr.2021.100028 · Cited by 2
Supervision of The Complement System by Toxoplasma During Neural Infections (Areview)
Alsaadawi, M. A., Alkhuzaie, S. S. H., Alasadiy, Y. D. K., Alsalih, N. J., & Al-Yasari, A. M. R. (2021) · IOP Conference Series Earth and Environmental Science · doi:10.1088/1755-1315/923/1/012047 · Cited by 4
Gaber, A. M., Ahmed, O. M., Khadrawy, Y. A., Zoheir, K. M. A., Abo‐Eleneen, R. E., Alblihed, M. A., & El-Bakry, A. M. (2023) · Biology · doi:10.3390/biology12070905 · Cited by 3
The Late Stage of Abnormal Aging: Dementia
Gao, S., Wang, Y., Ma, T., & Zhang, J. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-981-99-1627-6_12 · Cited by 2
Neuroinflammation in Age-Related Neurodegenerative Diseases
MacPherson, K. P., Rodrigues, M. E. D. S., Cintron, A. F., & Tansey, M. G. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811304-2.00016-x · Cited by 3
Blank-Stein, N., Mayer, M., & Mass, E. (2021) · Advances in immunology · doi:10.1016/bs.ai.2021.08.001 · Cited by 4
Davalos, D., Akassoglou, K., & Cardona, A. E. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-814405-3.00041-2 · Cited by 3
3D Mapping Reveals Network-specific Amyloid Progression and Subcortical SusceptibilityPreprint
Canter, R. G., Choi, H., Wang, J., Watson, L. A., Yao, C., Abdurrob, F., Bousleiman, S. M., Delalle, I., Chung, K., & Tsai, L.-H. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/116244 · Cited by 2
Pickett, E. K., Herrmann, A. G., McQueen, J., Abt, K. M., Dando, O., Tulloch, J., Jain, P., Dunnett, S. L., Sohrabi, S., Fjeldstad, M. P., et al. (2018) · SSRN Electronic Journal · doi:10.1101/393405 · Cited by 2
“Some of the toxic effects of Aß appear to be mediated by cascades which are normally involved in the innate immune system including complement and TREM2 (Hong et al., 2016; Jay et al., 2017; Yeh et al., 2016).”
BackgroundInfluentialComplement 3 signaling is necessary for the developmental refinement of olfactory bulb circuitryPreprint
Lehmann, K. S., Wood, A. N., Cummings, D. M., Bai, L., Stevens, B., & Belluscio, L. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/449454 · Cited by 2
“, 2012) and hippocampus (Paolicelli & Gross, 2011), and that much of this pruning is dependent on complement 3 signaling (Schafer et al., 2012; Bahrini et al., 2015; Hong et al., 2016).”
BackgroundInfluentialSelf-citationKilinc, D., Vreulx, A.-C., Mendes, T., Flaig, A., Coelho, D. M., Verschoore, M., Demiautte, F., Amouyel, P., Bank, N.-C. B., Eysert, F., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2019.12.20.884205 · Cited by 2
“…(i) membrane-disrupting activity at high concentrations (Sepulveda et al., 2010); (ii) deleterious pruning of synapses by microglia activation (Hong et al., 2016); (iii) direct interaction of oligomeric forms with postsynaptic receptors, such as ionotrophic or metabotropic glutamate…”
BackgroundDols‐Icardo, O., Montal, V., Sirisi, S., López‐Pernas, G., Cervera‐Carles, L., Querol‐Vilaseca, M., Muñoz, L., Belbin, O., Alcolea, D. A., Molina‐Porcel, L., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.02.07.938662 · Cited by 2
Feng, B., Freitas, A. E., Tian, R., Lee, Y. R., Grewal, A. S., Wang, J., & Zou, Y. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.09.09.273011 · Cited by 3
Iyer, H., Shen, K., Meireles, A. M., & Talbot, W. S. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.10.27.357897 · Cited by 2
Brelstaff, J., Mason, M., Katsinelos, T., McEwan, W. A., Ghetti, B. F., Tolkovsky, A. M., & Spillantini, M. G. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.02.26.433088 · Cited by 2
Loss of TREM2 reduces hyperactivation of progranulin deficient microglia but not lysosomal pathologyPreprint
Reifschneider, A., Robinson, S., van Lengerich, B., Gnörich, J. S., Logan, T., Heindl, S., Vogt, M. A., Weidinger, E., Riedl, L., Wind-Mark, K., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.07.08.451574 · Cited by 2
“Although, increased TREM2 may be protective in AD patients (Ewers et al., 2019), in other neurodegenerative diseases microglia may be overactivated and become dysfunctional (Heneka et al., 2013; Hong et al., 2016a; Ransohoff, 2016).”
BackgroundStructure of the integrin receptor αMβ2 headpiece in complex with a function-modulating nanobodyPreprint
Jensen, R. K., Pedersen, H., Lorentzen, J., Laursen, N., Vorup-Jensen, T., & Andersen, G. (2021) · bioRxiv · doi:10.1101/2021.07.07.451531 · Cited by 2
“Function modulating molecules targeting αMβ2 In vivo studies leave no doubt about the importance of the αMβ2 as a protective agent against infection (46) and as an aggravating factor in diseases with a poorly regulated inflammatory response, for instance, as observed in animal models of multiple sclerosis and Alzheime…”
BackgroundCarbajosa, G., Malki, K., Lawless, N., Wang, H., Ryder, J. W., Wozniak, E., Wood, K., Mein, C. A., Hodgkinson, A., Dobson, R., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.07.16.452732 · Cited by 2
“Complement activation is a well recognised response in AD brain (Hong et al., 2016; Morgan, 2018) and is a normal developmental mechanism for sculpting neural circuits (Schafer et al., 2012), but what has not previously been recognised is the central position the TREM2 pathway may play in this…”
BackgroundAutophagy in DG engrams mediates Rac1-dependent forgetting via TLR2/4 signals in microgliaPreprint
Wang, Z., Chen, R., Lin, Q., Jiang, Y., Le, Q., Liu, X., Ma, L., & Wang, F. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.08.26.457763 · Cited by 2
Complement protein C1q is a therapeutic target for neuropathic painPreprint
Yousefpour, N., Tansley, S. N., Locke, S., Sharif, B., Parisien, M., Deamond, H., Mathur, V., Yednock, T. A., Austin, J., Bourassa, V., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-1016420/v1 · Cited by 3
LRRK2 regulates synaptic function through modulation of actin cytoskeletal dynamics
Tombesi, G., Kompella, S. N., Favetta, G., Chen, C., Ornaghi, M., Zhao, Y., Morosin, E., Sevegnani, M., Lama, A., Marte, A., et al. (2026) · eLife · doi:10.1101/2022.10.31.514622 · Cited by 5
“…as early pathological events preceding neurodegeneration and the manifestation of clinical symptoms in multiple neurodegenerative disorders, including Parkinson’s disease (PD) ( Fiala et al., 2002 ; Hong et al., 2016 ; Milnerwood and Raymond, 2010 ; Soukup et al., 2018 ; Picconi et al., 2012 ).”
Boeddrich, A., Haenig, C., Neuendorf, N., Blanc, E., Ivanov, A., Kirchner, M., Schleumann, P., Bayraktaroğlu, I., Richter, M., Molenda, C., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.01.16.523715 · Cited by 2
Rachad, E. Y. (2023) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-9845 · Cited by 3
Editorial: Complement in nervous system disease
Michailidou, I., Fluiter, K., Boziki, M. K., Grigoriadis, N., & Baas, F. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1268023 · Cited by 2
“, 2021) and experimental models of neurodegenerative diseases (Hong et al., 2016; Paolicelli et al., 2017; Michailidou et al., 2018) supported this finding and showed an effect of complement-mediated synaptic pruning on behavior (Lui et al.”
BackgroundBlocking Formation of Neurotoxic Reactive Astrocytes is Beneficial Following StrokePreprint
Prescott, K., Münch, A. E., Brahms, E., Weigel, M. K., Inoue, K., Buckwalter, M. S., Liddelow, S. A., & Peterson, T. C. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.10.11.561918 · Cited by 2
“Developmentally, C1q is integral for correct synapse pruning by microglia (Stevens et al., 2007) – a mechanism that is also integral in neurodegenerative diseases like Alzheimer’s (Hong et al., 2016).”
BackgroundGomez, A. R., Byun, H. R., Wu, S., Muhammad, A. G., Ikbariyeh, J., Chen, J., Muro, A., Li, L., Bernstein, K. E., Ainsworth, R. I., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.04.24.590837 · Cited by 2
Narasipura, S. D., Zayas, J. P., Ash, M. K., Reyes, A. F., Shull, T. L., Gambut, S., Schneider, J. R., Lorenzo-Redondo, R., Al‐Harthi, L., & Mamede, J. I. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.06.13.598579 · Cited by 2
“At the same time, heightened complement activation could be detrimental and is associated with cognitive impairment because of excessive pruning 77– 79 .”
BackgroundVicidomini, C., Goode, T. D., McAvoy, K. M., Yu, R., Beveridge, C. H., Iyer, S. N., Victor, M. B., Leary, N., Evans, L., Steinbaugh, M. J., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.07.26.605338 · Cited by 7
Microglia determine ß-amyloid plaque burden but are non-essential for downstream pathologyPreprint
Li, M., Holt, K., Ridley, K., Qiu, J., Haddow, K., Vasoya, D., He, X., Tulloch, J., King, D., Hume, D. A., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.08.06.606795 · Cited by 4
“In the context of synapse loss in AD, studies in models of ß-amyloidopathy have proposed microglial phagocytosis as a mechanism, involving complement components or other synaptic “eat me” signals like phosphatidylserine 14-16 .”
BackgroundGlia in Neurodegenerative Disease
Crowley, G., Attwell, D., Phatnani, H. P., Sontheimer, H. W., & Hong, S. Y. (2024) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a041375 · Cited by 3
“Interestingly, this synaptic engulfment pathway in microglia is aberrantly reactivated in various models of AD in a re-gion-speci fi c manner to mediate synapse loss and dysfunction (Hong et al. 2016; Lui et al. 2016; Shi et al. 2017; Dejanovic et al. 2018; Wu et al. 2019).”
Self-citationComplement system alteration in iPSC-derived astrocytes from individuals with Down syndromePreprint
Silva, A. L. T. E., de Oliveira, P. H. P., Yokota-Moreno, B. Y., Avila, J. P., Nakaya, H. I., Fausto, J. D. S., Sertie, A. L., & Zampieri, B. L. (2024) · Research Square · doi:10.21203/rs.3.rs-5319960/v1 · Cited by 2
Patil, S. P., Kuehn, B. R., McCullough, C., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.01.03.631209 · Cited by 2
Submicron-Sampling of Living Cells by MacrophagesPreprint
Fan, A. C., Thota, R. R., Serwas, N. K., Vykunta, V. S., Marchuk, K., Ruhland, M. K., Liu, L., Johnson, G., Edwards, A. W., & Krummel, M. F. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.04.10.648051 · Cited by 2
Adult human ex vivo brain slices for dissecting glial biology and multicellular communicationPreprint
Adam, M., Shapira, I., Schoffman, H., Piester, G., Li, Z., Quintana, F. J., Paldor, I., Shahar, T., & Habib, N. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.01.12.698855 · Cited by 2
“Glial cells are increasingly recognized as key modulators of brain physiology 1,2 and as primary drivers of various neurodegenerative diseases, neuroinflammation, brain aging and injury 3–5 .”
Boers-Escuder, C., Kater, M. S. J., van der Zwan, M., Gouwenberg, Y., Klaassen, R. V., Huffels, C. F. M., Pekny, M., Hol, E. M., Smit, A. B., & Verheijen, M. H. G. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.03.24.713865 · Cited by 2
Role of Astrocytic Serine in Learning and Memory and its Implications in Alzheimer's Disease.
Maugard, M. (2018) · theses.fr (ABES) · doi:10.70675/2a0528d8zc687z43e6za9b4zfa45cdb5b6d9 · Cited by 4
Zhang, Q., Ao, L., Liu, J., Xi, Y., & Chen, D. (2024) · International Conference on Computer Supported Cooperative Work in Design (CSCWD) · doi:10.1109/cscwd61410.2024.10580265 · Cited by 1
Зв’язок між мікробіомом кишечника та розвитком нейродегенеративних захворювань (огляд)
Широбоков, В. П., & Димент, Г. С. (2024) · Visnik Nacional noi academii nauk Ukrai ni · doi:10.15407/visn2024.07.077 · Cited by 2
Metadata
- Authors
- Hong, S., Beja-Glasser, V. F., Nfonoyim, B. M., Frouin, A., Li, S., Ramakrishnan, S., Merry, K. M., Shi, Q., Rosenthal, A., Barres, B. A., Lemere, C. A., Selkoe, D. J., & Stevens, B.
- Affiliations
- Boston Children's Hospital (US)
- Brigham and Women's Hospital (US)
- University of California, San Francisco (US)
- Stanford Medicine (US)
- Broad Institute (US)
- Corresponding author
- Beja-Glasser, Victoria F.
- Nfonoyim, Bianca M.
- Stevens, Beth
- ORCID
- Venue
- Science
- Published
- 2016-05-06
- Volume
- 352
- Issue
- 6286
- Pages
- 712-716
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC5094372
- OpenAlex
- W2314634699
- Cited by
- 3,343
- References
- 33
- Citations by year
- 2026: 415 · 2025: 391 · 2024: 384 · 2023: 388 · 2022: 324 · 2021: 363 · 2020: 306 · 2019: 260 · 2018: 240 · 2017: 198 · 2016: 69
- FWCI
- 140.04
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Edward R. and Anne G. Lefler Fellowship
- Coins for Alzheimer's Research Trust
- Fidelity Biosciences Research Initiative
- JPB Foundation
- National Institutes of Health (AG000222)
- National Institute of Neurological Disorders and Stroke-NIH (R01NS083845)
- National Institute on Aging-NIH (1RF1AG051496A)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- Alzheimer's disease, synaptic loss, complement system, microglia, C1q, CR3, complement C3, soluble amyloid-beta oligomers, neuroinflammation, synaptic pruning, hippocampal long-term potentiation, phagocytosis, mouse model
- MeSH terms
- Disks Large Homolog 4 Protein, Alzheimer Disease, Animals, Cognition Disorders, Complement Pathway, Classical, Disease Models, Animal, Membrane Proteins, Phagocytosis, Synapses, Up-Regulation, Complement C1q, Macrophage-1 Antigen, Amyloid beta-Peptides, Synaptophysin, Microglia, Long-Term Potentiation, Mice, Knockout, Mice, Guanylate Kinases, CA1 Region, Hippocampal, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.